Zahrawi Group Company Profile

Background

Established in 1989, Zahrawi Group is a leading provider of medical devices and life science solutions in the Gulf Cooperation Council (GCC) region, including the United Arab Emirates (UAE), Saudi Arabia, Qatar, Bahrain, and Oman. The company specializes in diagnostic and analytical laboratories, medical, surgical, and cardiovascular products. Zahrawi Group represents over 70 international manufacturers, such as Medtronic, Sysmex, Smith & Nephew, Mallinckrodt, Dako, Sakura, Laborie, and Hitachi. The company's mission is to provide top-quality products, services, and support to customers in the medical and laboratory industries, fostering long-term loyalty.

Key Strategic Focus

Zahrawi Group's strategic focus includes:

Core Objectives: Delivering high-quality healthcare solutions and services across the GCC region.

Areas of Specialization: Diagnostic and analytical laboratories, medical, surgical, and cardiovascular products.

Key Technologies Utilized: Advanced medical devices and diagnostic equipment from internationally renowned manufacturers.

Primary Markets Targeted: Hospitals, clinics, laboratories, and analytical industries within the GCC region.

Financials and Funding

In 2021, Zahrawi Group achieved revenues of AED 694 million. The company aims to reach the SAR 1 billion milestone by 2024, as per its growth plan.

Pipeline Development

Zahrawi Group collaborates with a diverse portfolio of international healthcare manufacturers to meet the growing local and regional demand. The company's product offerings include:

Surgical Instrumentation Unit: Weight loss solutions, high-tech bariatric surgery products, multivitamins tailored to specific surgery types, stapling, and laparoscopic instruments for multiple specialties and procedures.

Soft Tissue Management Unit: Innovative products for open and laparoscopic hernia repair procedures, as well as wound care solutions.

Surgical Equipment Unit: Comprehensive solutions for various surgical needs.

Hematology & Biochemistry Unit: State-of-the-art medical and diagnostic equipment and consumables for routine and specialized tests in hematology, biochemistry, serology, and virology departments.

Molecular, Immunology, and Microbiology Unit: Detection of genomic variants to facilitate detection, diagnosis, subclassification, prognosis, and monitoring response to therapy.

Analytical Chemistry Unit: High-end instrumentation solutions such as thermal analysis, mass spectrometry, and biochemistry analyzers for various market sectors, including oil and gas, academics, research, forensic, veterinary, food, and environment.

Technological Platform and Innovation

Zahrawi Group's technological platform includes:

Proprietary Technologies: The company collaborates with over 70 international manufacturers to provide a diverse range of medical devices and diagnostic equipment.

Significant Scientific Methods: Utilizes advanced diagnostic equipment and medical devices from internationally renowned manufacturers to deliver high-quality healthcare solutions.

Leadership Team

The leadership team at Zahrawi Group includes:

Abdulrahman Ramadan: Vice President & Acting CEO.

Eissa Mahmoud: Group Director.

Youssef Afifi: Group Finance Director.

Market Insights and Dynamics

The GCC healthcare industry is experiencing significant growth, driven by increasing demand for high-quality medical devices and diagnostic equipment. This growth presents opportunities for companies like Zahrawi Group to expand their market presence and enhance service offerings.

Competitor Analysis

Key competitors in the GCC region include:

Kotra Pharma: A pharmaceutical company based in Melaka, Malaysia, with 367 employees.

Nutramedix: A producer of nutraceutical products located in Jupiter, USA, employing 33 people.

Accura Care: A pharmaceutical company based in India, with 16 employees.

XL Laboratories: A pharmaceutical and nutraceutical manufacturing company headquartered in New Delhi, India, employing 218 people.

Strategic Collaborations and Partnerships

Zahrawi Group has established partnerships with over 70 international manufacturers, including Medtronic, Sysmex, Smith & Nephew, Mallinckrodt, Dako, Sakura, Laborie, and Hitachi, to provide a diverse range of medical devices and diagnostic equipment.

Operational Insights

Zahrawi Group's strong operational support platform and commitment to high ethical standards contribute to its sustainable growth and ability to meet customer needs effectively.

Strategic Opportunities and Future Directions

Zahrawi Group aims to achieve SAR 1 billion in revenue by 2024, indicating a strategic focus on expanding its market presence and enhancing service offerings to meet the growing demand in the GCC healthcare industry.